You are here

Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42NS074734-02
Agency Tracking Number: R42NS074734
Amount: $723,863.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: 105
Solicitation Number: PA13-089
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): 2014-03-15
Award End Date (Contract End Date): 2016-02-29
Small Business Information
501 N GRAHAM, SUITE 250, Portland, OR, 97227-1651
DUNS: 831184044
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MICHAEL BOTTLANG
 (503) 413-5457
 mbottlang@biomechresearch.org
Business Contact
 MICHAEL BOTTLANG
Phone: (503) 528-4048
Email: bottlang@apexbiomed.com
Research Institution
 APEX BIOMEDICAL COMPANY, LLC
 501 N GRAHAM, SUITE 250
PORTLAND, OR, 97227-1651
 Domestic nonprofit research organization
Abstract
DESCRIPTION provided by applicant Traumatic brain injury TBI is an acquired neurological disorder that can cause long lasting disability with limited treatment options Therefore preventative strategies must be emphasized in high risk activities to reduce the individual and societal burden of this pervasive injury Bicycle activities account for of all sports related TBI with annual injuries in the US In an effort to alleviate the incidence and severity of these head injuries helmet usage is now recommended and in some states mandatory However contemporary bicycle helmets are not designed to mitigate rotational head acceleration which is a clear physical mechanism of TBI A novel helmet using High Impact Velocity Engineering HIVE technology is therefore proposed that combines recent advances in material science with an innovative suspension technique to provide superior energy absorption in a lightweight and cost effective design A key innovation of the HIVE helmet is that its structural properties behave similar to a torsional spring and damper and thus enable the HIVE helmet to attenuate severe rotational head accelerations The STTR Phase I delivered conclusive evidence on the feasibility of HIVE technology HIVE prototype helmets yielded up to reduction in rotational head acceleration and up to reduction in predicted TBI risk compared to standard bicycle helmets The aim of this STTR Phase II research and development strategy is to formally optimize the performance of HIVE technology by combining computational modeling and physical validation The optimized HIVE technology will be translated into a commercially viable helmet design The resulting HIVE helmets will be evaluated in vertical and oblique impacts to quantify performance improvements compared to standard helmets If successful the final HIVE helmet design can readily be commercialized to offer advanced head protection for bicyclists and to reduce the incidence and severity of bicycle related TBI PUBLIC HEALTH RELEVANCE There are bicycle related traumatic brain injuries TBI that occur annually in the U S with an associated societal cost of $ billion per year Althoug bicycle helmets should offer a clear preventative strategy to reduce bicycle related TBI contemporary bicycle helmets are not engineered to attenuate rotational head acceleration a primary physical mechanism of TBI A helmet impact mitigation technology is proposed that absorbs rotational energy and therefore will potentially reduce the high incidence of bicycle related TBI

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government